Filter Reports by Region
sale
Ramipril Market: Global Opportunity Analysis and Industry Forecast, 2023-2032
Ramipril (brand name: Altace) is a type of medicine that belongs to the class of angiotensin-converting enzyme (ACE) inhibitor therapeutics, which lowers the production of angiotensin II (increases blood pressure) and decreases the breakdown of bradykinin (promoted inflammation).
Report Code : A14845 | Category : Life Sciences
